Preoperative Chemoradiotherapy with Concomitant Small Field Boost Irradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Phase II Study (KROG 04-01)

Dae Yong Kim(National Cancer Center), Sei‐Chul Yoon(St. Mary’s Hospital), Seong Yeob Ryu(Chonnam National University), Doo Suk Lee(Daehang Hospital), Seok‐Byung Lim(National Cancer Center), Seung‐Yong Jeong(Seoul National University), Jin‐Hyoung Kang(The Catholic University of Korea Seoul St. Mary's Hospital), Kyung Hae Jung(University of Ulsan), Taek‐Keun Nam(Chonnam National University), Tae Hyun Kim(Sookmyung Women's University), Sung Il Choi, Hyo Seong Choi(National Cancer Center), Hee Jin Chang(National Cancer Center)
Diseases of the Colon & Rectum
September 20, 2006
10.1007/s10350-006-0678-z
Cited by 15

Related Papers

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
|The Lancet|2020|1.1k
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
|The Lancet Oncology|2018|1k
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673
Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer
|JAMA Oncology|2019|508
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
|The Lancet Oncology|2021|401